Stephen H Hand, MD
Pulmonary Disease · Anderson
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 43 years
- Medical University of South Carolina College of Medicine, 1983
Offices
2 locations · Anmed Health · 348 clinicians in this group
Hospitals listed: Anmed Health · Cannon Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hand’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Anmed HealthAnderson, SCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of AnMed Health, which runs 2 hospitalsPatients rate it 4 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.228, Oct 2024 – Sep 2025
- Cannon Memorial HospitalPickens, SCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of AnMed Health, which runs 2 hospitals83% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Anmed Health
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.228 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0 to 1.73) · 1,363 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.77 (0.47 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.62 (118.62 to 222.63) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.7 · 252 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 855 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.6 · 396 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,142 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.04 to 0.43) · 7,859 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.12 to 0.5) · 8,065 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.29 (2.24 to 6.34) · 1,675 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.79 (1.34 to 4.24) · 1,567 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.25 (0 to 12.76) · 712 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.93 (0.47 to 7.4) · 692 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.89 (0.44 to 3.34) · 349 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.15 (0 to 0.79) · 6,928 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.78 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.904 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.75 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 225 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 848 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.8 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 19.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.3 · 881 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 1,368 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.4 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (6.2 to 14) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.2 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 569 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.1 to 16) · 1,702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 686 cases | No different | Jan 2024 – Dec 2024 |
What patients said (626 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Cannon Memorial Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.48 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 177 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 260 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0 to 1.91) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 29 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.4 · 56 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.6) · 89 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 92% |
| Doctors "always" communicated well | 91% |
| Staff "always" explained | 80% |
| Yes, staff "did" give patients this information | 97% |
| Yes, staff "did" give patients information about help after discharge | 95% |
| Doctors "always" explained things so they could understand | 88% |
| Doctors "always" listened carefully | 90% |
| Doctors "always" treated them with courtesy and respect | 93% |
| Patients who gave a rating of "9" or "10" (high) | 89% |
| Staff "always" explained new medications | 89% |
| Nurses "always" explained things so they could understand | 86% |
| Nurses "always" listened carefully | 94% |
| Nurses "always" treated them with courtesy and respect | 97% |
| "Always" quiet at night | 87% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 70% |
| Yes, staff "did" give patients information about possible symptoms | 99% |
Original Medicare doctor bills
$93,964
Medicare paid this office $93,964 for 608 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 161 | $21,180 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $15,700 | $61 |
| Short return visit (20+ min) | 169 | $11,916 | $63 |
| Critical care, first 30-74 minutes | 19 | $7,781 | $162 |
| New patient visit (30+ min) | 65 | $5,001 | $77 |
See all 25 services
| Return visit (30+ min) | 161 | $21,180 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $15,700 | $61 |
| Short return visit (20+ min) | 169 | $11,916 | $63 |
| Critical care, first 30-74 minutes | 19 | $7,781 | $162 |
| New patient visit (30+ min) | 65 | $5,001 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $4,815 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $4,792 | $100 |
| Sleep study in sleep lab (6 years or older) | 39 | $3,591 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,274 | $126 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,488 | $96 |
| New patient visit (45+ min) | 20 | $2,245 | $112 |
| Sleep study including heart rate, breathing, airflow, and effort | 41 | $1,405 | $34 |
| Sleep study in sleep lab (6 years or older) | 18 | $1,362 | $76 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,013 | $92 |
| Test for exercise-induced lung stress | 33 | $550 | $17 |
| Test for exercise-induced lung stress | 29 | $483 | $17 |
| Test to examine how well the lungs exchange gases | 55 | $344 | $6 |
| Test to determine lung volumes using sensors | 40 | $334 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 37 | $270 | $7 |
| Test to determine lung volumes using sensors | 29 | $252 | $9 |
| Test to examine how well the lungs exchange gases | 36 | $228 | $6 |
| Test to measure expiratory airflow and volume | 27 | $152 | $6 |
| Test to determine lung volumes using gas dilution or washout | 15 | $130 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $127 | $7 |
| Test to measure expiratory airflow and volume | 18 | $108 | $6 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Irrigation and suction of lung airways to obtain cells using an endoscope | 35 | 25 | 18 | 13 | 14 | – |
| Aspiration of fluid from chest cavity using imaging guidance | – | 12 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
608 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 48% · Also on Medicaid 7% · Health risk score 1.61. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · COPD 44% · Diabetes 43% · Chronic kidney disease 33% · Heart failure 32% · Atrial fibrillation 30% · Depression 28% · Cancer 16% · Stroke 9% · Dementia 7%.
The office billed $309,979, Medicare allowed $123,164 and paid $93,964; for 1,484 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 608 | 1,484 | 75 | 1.61 | $309,979 | $93,964 |
| 2023 | 631 | 1,666 | 74 | 1.50 | $331,842 | $99,814 |
| 2022 | 615 | 1,521 | 74 | 1.46 | $300,234 | $88,858 |
| 2021 | 724 | 2,081 | 74 | 1.62 | $468,707 | $145,041 |
| 2020 | 886 | 2,616 | 73 | 2.04 | $559,576 | $170,856 |
| 2019 | 852 | 2,391 | 73 | 1.94 | $519,249 | $153,799 |
| 2018 | 957 | 2,840 | 73 | 1.93 | $678,850 | $176,632 |
| 2017 | 913 | 2,614 | 74 | 1.93 | $644,706 | $179,266 |
| 2016 | 1,127 | 2,999 | 72 | 1.95 | $754,603 | $217,270 |
| 2015 | 1,398 | 4,429 | 72 | 1.93 | $960,114 | $276,845 |
| 2014 | 1,255 | 4,279 | 72 | 1.78 | $910,789 | $258,429 |
| 2013 | 1,089 | 3,918 | 71 | 1.80 | $841,897 | $241,816 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Return visit (30+ min) | 176 | $25,028 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 110 | $16,406 | $60 |
| Short return visit (20+ min) | 204 | $14,334 | $63 |
| Critical care, first 30-74 minutes | 30 | $9,659 | $164 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $4,854 | $95 |
| Sleep study in sleep lab (6 years or older) | 48 | $4,254 | $85 |
| New patient visit (30+ min) | 55 | $4,175 | $76 |
| New patient visit (45+ min) | 26 | $3,137 | $121 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 30 | $2,927 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $2,853 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $2,671 | $86 |
| Test for exercise-induced lung stress | 70 | $1,183 | $16 |
| Sleep study including heart rate, breathing, airflow, and effort | 37 | $1,086 | $29 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $707 | $51 |
| Test to examine how well the lungs exchange gases | 99 | $644 | $7 |
| Test to determine lung volumes using sensors | 64 | $559 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 61 | $443 | $7 |
| Test to measure expiratory airflow and volume | 54 | $328 | $6 |
| Test to determine lung volumes using gas dilution or washout | 34 | $300 | $9 |
| Test to measure the level of nitric oxide gas | 11 | $110 | $10 |
2022: 20 services
| Return visit (30+ min) | 157 | $19,966 | $88 |
| Short return visit (20+ min) | 223 | $14,076 | $58 |
| Critical care, first 30-74 minutes | 32 | $13,346 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $12,133 | $53 |
| New patient visit (30+ min) | 64 | $4,222 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $3,585 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,340 | $78 |
| Sleep study in sleep lab (6 years or older) | 33 | $2,948 | $89 |
| New patient visit (45+ min) | 24 | $2,854 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,481 | $155 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 19 | $1,819 | $83 |
| Sleep study including heart rate, breathing, airflow, and effort | 39 | $1,209 | $31 |
| Test for exercise-induced lung stress | 69 | $1,182 | $16 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $926 | $71 |
| Test to examine how well the lungs exchange gases | 94 | $632 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 72 | $553 | $8 |
| Test to determine lung volumes using gas dilution or washout | 51 | $455 | $9 |
| Test to determine lung volumes using sensors | 43 | $390 | $9 |
| Test to measure expiratory airflow and volume | 36 | $221 | $6 |
| Test to measure the level of nitric oxide gas | 12 | $179 | $12 |
2021: 19 services
| Critical care, first 30-74 minutes | 78 | $37,430 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 172 | $25,442 | $54 |
| Return visit (30+ min) | 135 | $18,626 | $98 |
| Short return visit (20+ min) | 247 | $18,168 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 96 | $11,747 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $6,162 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,104 | $176 |
| New patient visit (30+ min) | 48 | $3,911 | $81 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 28 | $3,028 | $98 |
| Sleep study in sleep lab (6 years or older) | 25 | $2,473 | $95 |
| New patient visit (45+ min) | 14 | $1,853 | $132 |
| Test for exercise-induced lung stress | 73 | $1,350 | $18 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $1,167 | $65 |
| Test to examine how well the lungs exchange gases | 118 | $815 | $7 |
| Sleep study including heart rate, breathing, airflow, and effort | 25 | $812 | $32 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 85 | $679 | $8 |
| Test to determine lung volumes using sensors | 67 | $613 | $9 |
| Test to determine lung volumes using gas dilution or washout | 50 | $479 | $9 |
| Test to measure expiratory airflow and volume | 45 | $287 | $6 |
2020: 27 services
| Critical care, first 30-74 minutes | 91 | $46,939 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 224 | $33,322 | $56 |
| Return visit (30+ min) | 148 | $17,483 | $76 |
| Short return visit (20+ min) | 258 | $15,156 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 103 | $11,553 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $11,211 | $84 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 50 | $5,356 | $94 |
| Sleep study in sleep lab (6 years or older) | 48 | $4,445 | $93 |
| New patient visit (30+ min) | 61 | $4,245 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,933 | $163 |
| New patient visit (45+ min) | 21 | $2,675 | $127 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 25 | $1,528 | $61 |
| Test for exercise-induced lung stress | 86 | $1,518 | $17 |
| Sleep study including heart rate, breathing, airflow, and effort | 33 | $1,084 | $33 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,050 | $48 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 107 | $1,035 | $9 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $938 | $78 |
| Test to examine how well the lungs exchange gases | 128 | $866 | $7 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $732 | $56 |
| Test to determine lung volumes using sensors | 71 | $680 | $9 |
| Short return visit | 15 | $504 | $34 |
| Test to determine lung volumes using gas dilution or washout | 56 | $485 | $9 |
| Test to measure the level of nitric oxide gas | 22 | $400 | $14 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $400 | $31 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $373 | $23 |
| Test to measure expiratory airflow and volume | 43 | $284 | $6 |
| Administration of influenza virus vaccine | 12 | $190 | $16 |
2019: 23 services
| Critical care, first 30-74 minutes | 77 | $32,085 | $170 |
| Return visit (30+ min) | 220 | $28,292 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 201 | $25,591 | $56 |
| Short return visit (20+ min) | 228 | $14,269 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 82 | $8,421 | $99 |
| Sleep study in sleep lab (6 years or older) | 59 | $5,628 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $5,062 | $79 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 46 | $4,750 | $93 |
| New patient visit (30+ min) | 67 | $4,680 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,559 | $142 |
| New patient visit (45+ min) | 33 | $3,595 | $109 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 35 | $2,508 | $72 |
| Short return visit | 66 | $1,944 | $29 |
| Test for exercise-induced lung stress | 87 | $1,666 | $17 |
| Sleep study including heart rate, breathing, airflow, and effort | 30 | $1,032 | $34 |
| Influenza vaccine, inactivated | 17 | $992 | $58 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 88 | $898 | $10 |
| Test to examine how well the lungs exchange gases | 103 | $732 | $7 |
| Test to determine lung volumes using gas dilution or washout | 55 | $516 | $9 |
| Test to determine lung volumes using sensors | 48 | $452 | $9 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $335 | $30 |
| Administration of influenza virus vaccine | 18 | $280 | $16 |
| Test to measure expiratory airflow and volume | 22 | $148 | $6 |
2018: 21 services
| Critical care, first 30-74 minutes | 91 | $38,487 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 262 | $34,979 | $53 |
| Return visit (30+ min) | 213 | $24,411 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $14,902 | $77 |
| Short return visit (20+ min) | 231 | $13,242 | $49 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 124 | $11,751 | $93 |
| Sleep study in sleep lab (6 years or older) | 62 | $5,761 | $91 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 52 | $4,385 | $78 |
| New patient visit (30+ min) | 65 | $4,356 | $67 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 41 | $4,014 | $98 |
| New patient visit (45+ min) | 35 | $3,860 | $110 |
| Short return visit | 95 | $2,789 | $29 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 11 | $1,526 | $139 |
| Test for exercise-induced lung stress | 98 | $1,424 | $14 |
| Test to examine how well the lungs exchange gases | 133 | $919 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 86 | $842 | $10 |
| Test to determine lung volumes using gas dilution or washout | 78 | $725 | $9 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $507 | $30 |
| Test to determine lung volumes using sensors | 56 | $506 | $9 |
| Test to measure expiratory airflow and volume | 45 | $277 | $6 |
| Administration of influenza virus vaccine | 13 | $248 | $19 |
2017: 23 services
| Critical care, first 30-74 minutes | 113 | $37,947 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 293 | $37,725 | $54 |
| Return visit (30+ min) | 211 | $24,229 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $17,830 | $79 |
| Short return visit (20+ min) | 196 | $11,252 | $49 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 68 | $6,986 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,455 | $150 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 58 | $5,992 | $92 |
| New patient visit (45+ min) | 44 | $4,903 | $111 |
| Sleep study in sleep lab (6 years or older) | 44 | $4,219 | $94 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 41 | $3,976 | $95 |
| New patient visit (30+ min) | 35 | $2,402 | $69 |
| Short return visit | 72 | $2,111 | $29 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 11 | $2,071 | $173 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,307 | $77 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,258 | $84 |
| Pulmonary exercise testing | 57 | $1,229 | $21 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $569 | $27 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 49 | $497 | $10 |
| Test to examine how well the lungs exchange gases | 70 | $495 | $7 |
| Test to determine lung volumes using gas dilution or washout | 40 | $392 | $10 |
| Test to determine lung volumes using sensors | 30 | $277 | $9 |
| Administration of influenza virus vaccine | 11 | $259 | $24 |
2016: 22 services
| Critical care, first 30-74 minutes | 110 | $43,925 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 324 | $43,356 | $55 |
| Return visit (30+ min) | 279 | $29,958 | $73 |
| Short return visit (20+ min) | 334 | $19,542 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $13,043 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $12,616 | $78 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 86 | $8,543 | $92 |
| New patient visit (45+ min) | 60 | $6,716 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 61 | $6,662 | $104 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 67 | $6,442 | $96 |
| Sleep study in sleep lab (6 years or older) | 59 | $5,292 | $88 |
| Short return visit | 81 | $2,490 | $30 |
| New patient visit (30+ min) | 33 | $2,429 | $74 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 12 | $1,394 | $116 |
| Aspiration of fluid from chest cavity using imaging guidance | 13 | $1,126 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $899 | $29 |
| Administration of influenza virus vaccine | 30 | $695 | $23 |
| Influenza vaccine split virus, preservative free | 15 | $628 | $42 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 15 | $277 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 36 | $267 | $6 |
| Administration of pneumococcal vaccine | 11 | $237 | $22 |
| Injection of drug or substance under skin or into muscle | 12 | $204 | $17 |
2015: 30 services
| Return visit (30+ min) | 372 | $47,405 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 339 | $44,539 | $55 |
| Critical care, first 30-74 minutes | 104 | $39,151 | $170 |
| Short return visit (20+ min) | 541 | $36,605 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $19,737 | $79 |
| Pneumococcal vaccine, 13-valent | 74 | $12,105 | $164 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 119 | $11,440 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $9,182 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 74 | $7,546 | $101 |
| New patient visit (45+ min) | 61 | $7,011 | $115 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 61 | $6,314 | $97 |
| Sleep study in sleep lab (6 years or older) | 56 | $4,940 | $88 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 19 | $3,075 | $154 |
| New patient visit (30+ min) | 39 | $2,614 | $67 |
| Short return visit | 86 | $2,595 | $29 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 20 | $2,130 | $97 |
| Administration of influenza virus vaccine | 86 | $2,000 | $23 |
| New patient visit (60+ min) | 11 | $1,713 | $156 |
| Administration of pneumococcal vaccine | 74 | $1,617 | $22 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 84 | $1,487 | $18 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,384 | $73 |
| Ultrasound of lung airways using an endoscope | 23 | $1,290 | $52 |
| Injection of drug or substance under skin or into muscle | 54 | $1,170 | $17 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,015 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $917 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $804 | $30 |
| Evaluation of use of breathing device | 56 | $738 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $338 | None |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 11 | $27 | None |
| Injection, ceftriaxone sodium, per 250 mg | 19 | $12 | None |
2014: 28 services
| Return visit (30+ min) | 372 | $51,959 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 338 | $43,498 | $53 |
| Critical care, first 30-74 minutes | 86 | $37,547 | $165 |
| Short return visit (20+ min) | 491 | $33,258 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 137 | $20,723 | $78 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 106 | $13,400 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 112 | $11,511 | $98 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 64 | $6,225 | $93 |
| New patient visit (45+ min) | 50 | $6,028 | $121 |
| Sleep study in sleep lab (6 years or older) | 50 | $4,698 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,712 | $148 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 18 | $2,751 | $145 |
| Short return visit | 80 | $2,341 | $28 |
| New patient visit (30+ min) | 28 | $2,128 | $76 |
| Aspiration of fluid from chest cavity using imaging guidance | 21 | $1,882 | $86 |
| New patient visit (60+ min) | 13 | $1,849 | $142 |
| Biopsy of lung airway using an endoscope | 12 | $1,582 | $132 |
| Ultrasound of lung airways using an endoscope | 28 | $1,429 | $51 |
| Administration of influenza virus vaccine | 50 | $1,141 | $23 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,105 | $29 |
| Pneumococcal vaccine, 23-valent | 12 | $910 | $76 |
| Injection of drug or substance under skin or into muscle | 42 | $859 | $17 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 51 | $681 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 78 | $568 | $6 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 39 | $510 | None |
| Evaluation of use of breathing device | 32 | $427 | $12 |
| Administration of pneumococcal vaccine | 11 | $237 | $22 |
| Test to measure expiratory airflow and volume | 11 | $71 | $6 |
2013: 26 services
| Return visit (30+ min) | 337 | $51,181 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 319 | $42,183 | $52 |
| Critical care, first 30-74 minutes | 112 | $35,312 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 168 | $27,466 | $76 |
| Short return visit (20+ min) | 357 | $23,288 | $48 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 92 | $11,064 | $103 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 105 | $10,223 | $95 |
| New patient visit (45+ min) | 77 | $8,695 | $113 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 54 | $4,708 | $86 |
| Sleep study in sleep lab (6 years or older) | 46 | $3,958 | $86 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 23 | $3,283 | $131 |
| New patient visit (60+ min) | 17 | $2,493 | $147 |
| New patient visit (30+ min) | 25 | $1,803 | $72 |
| Biopsy of lung airway using an endoscope | 16 | $1,792 | $112 |
| Ultrasound of lung airways using an endoscope | 26 | $1,648 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 48 | $1,562 | $27 |
| Short return visit | 38 | $1,065 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $881 | $14 |
| Pneumococcal vaccine, 23-valent | 12 | $851 | $71 |
| Administration of influenza virus vaccine | 37 | $813 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 99 | $649 | $6 |
| Injection of drug or substance under skin or into muscle | 28 | $546 | $17 |
| Blood test, clotting time | 15 | $526 | $5 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 39 | $455 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $322 | None |
| Administration of pneumococcal vaccine | 12 | $259 | $22 |
Medicaid work
$480 in 2023
Medicaid paid $480 for 16 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 16 | $480 |
| 2023 | 16 | 1 | 16 | $480 |
| 2020 | 155 | 1 | 18 | $4,761 |
| 2019 | 52 | 1 | 13 | $2,107 |
| 2018 | 234 | 2 | 22 | $9,787 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 155 | $4,761 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 52 | $2,107 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 204 | $5,745 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 30 | $4,042 |
Drugs they prescribed that Part D paid
$485,542
Pharmacies billed $485,542 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,135) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
481 generic and 654 brand-name prescriptions · $485,542 in drug cost · 19 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Wakix | 12 | $188,928 | $15,744 |
| Trelegy Ellipta | 95 | $99,989 | $1,053 |
| Stiolto Respimat | 76 | $41,496 | $546 |
| Breztri Aerosphere | 48 | $35,354 | $737 |
| Breo Ellipta | 41 | $17,747 | $433 |
See all 27 drugs
| Wakix | 12 | $188,928 | $15,744 |
| Trelegy Ellipta | 95 | $99,989 | $1,053 |
| Stiolto Respimat | 76 | $41,496 | $546 |
| Breztri Aerosphere | 48 | $35,354 | $737 |
| Breo Ellipta | 41 | $17,747 | $433 |
| Anoro Ellipta | 39 | $17,729 | $455 |
| Symbicort | 30 | $12,995 | $433 |
| Albuterol Sulfate Hfa | 219 | $9,057 | $41 |
| Spiriva Handihaler | 13 | $7,352 | $566 |
| Budesonide-Formoterol | 32 | $6,469 | $202 |
| Wixela Inhub | 26 | $3,944 | $152 |
| Fluticasone-Salmeterol | 28 | $3,690 | $132 |
| Ventolin Hfa | 52 | $3,549 | $68 |
| Dextroamphetamine-Amphetamine | 20 | $1,090 | $55 |
| Doxepin | 11 | $801 | $73 |
| Levalbuterol Tartrate Hfa | 14 | $732 | $52 |
| Modafinil | 22 | $599 | $27 |
| Montelukast | 58 | $316 | $5 |
| Temazepam | 17 | $188 | $11 |
| Clonazepam | 43 | $162 | $4 |
| Pramipexole Dihydrochloride | 13 | $122 | $9 |
| Trazodone | 22 | $100 | $5 |
| Prednisone | 39 | $69 | $2 |
| Tamsulosin | 12 | $34 | $3 |
| Azithromycin | 11 | $23 | $2 |
| Amlodipine Besylate | 12 | $21 | $2 |
| Omeprazole | 12 | $15 | $1 |
Year by year
| 2024 | 1,135 | 200 | 0% (0) | 58% | $485,542 |
| 2023 | 1,133 | 211 | None | 63% | $635,874 |
| 2022 | 1,186 | 223 | None | 66% | $589,318 |
| 2021 | 1,698 | 228 | 1% (22) | 64% | $1,045,665 |
| 2020 | 1,692 | 260 | 1% (22) | 63% | $1,351,757 |
| 2019 | 1,621 | 266 | 2% (33) | 65% | $1,227,134 |
| 2018 | 1,687 | 262 | 2% (32) | 63% | $1,545,090 |
| 2017 | 1,963 | 297 | 2% (31) | 61% | $1,546,994 |
| 2016 | 2,528 | 344 | 1% (19) | 62% | $1,826,977 |
| 2015 | 3,008 | 394 | 1% (21) | 64% | $1,605,766 |
| 2014 | 2,879 | 390 | None | 60% | $1,062,571 |
| 2013 | 2,150 | 319 | None | 60% | $548,041 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Wakix | 16 | $182,262 | $11,391 |
| Trelegy Ellipta | 105 | $94,278 | $898 |
| Breztri Aerosphere | 50 | $41,871 | $837 |
| Stiolto Respimat | 50 | $33,495 | $670 |
| Breo Ellipta | 58 | $27,503 | $474 |
| Anoro Ellipta | 51 | $26,053 | $511 |
| Symbicort | 40 | $21,737 | $543 |
| Spiriva Handihaler | 27 | $14,958 | $554 |
| Combivent Respimat | 28 | $14,218 | $508 |
| Eliquis | 17 | $12,690 | $746 |
| Albuterol Sulfate Hfa | 237 | $9,844 | $42 |
| Wixela Inhub | 19 | $5,260 | $277 |
| Fluticasone-Salmeterol | 19 | $5,119 | $269 |
| Roflumilast | 25 | $5,060 | $202 |
| Budesonide-Formoterol | 12 | $2,712 | $226 |
| Modafinil | 21 | $2,322 | $111 |
| Ventolin Hfa | 24 | $1,906 | $79 |
| Dextroamphetamine-Amphetamine | 15 | $947 | $63 |
| Methylphenidate | 20 | $459 | $23 |
| Temazepam | 23 | $245 | $11 |
| Montelukast | 31 | $210 | $7 |
| Doxepin | 11 | $114 | $10 |
| Prednisone | 31 | $79 | $3 |
| Pramipexole Dihydrochloride | 11 | $67 | $6 |
| Azithromycin | 13 | $55 | $4 |
| Clonazepam | 24 | $47 | $2 |
2022: 34 drugs
| Opsumit | 21 | $245,985 | $11,714 |
| Trelegy Ellipta | 65 | $51,649 | $795 |
| Breztri Aerosphere | 55 | $42,545 | $774 |
| Stiolto Respimat | 57 | $32,414 | $569 |
| Anoro Ellipta | 64 | $29,624 | $463 |
| Spiriva Respimat | 46 | $23,584 | $513 |
| Spiriva Handihaler | 31 | $22,682 | $732 |
| Symbicort | 38 | $17,243 | $454 |
| Breo Ellipta | 31 | $14,064 | $454 |
| Albuterol Sulfate Hfa | 204 | $11,380 | $56 |
| Flovent Hfa | 26 | $10,687 | $411 |
| Daliresp | 22 | $9,468 | $430 |
| Combivent Respimat | 11 | $8,265 | $751 |
| Bevespi Aerosphere | 18 | $7,814 | $434 |
| Wixela Inhub | 29 | $6,581 | $227 |
| Fluticasone-Salmeterol | 20 | $6,556 | $328 |
| Eliquis | 12 | $6,362 | $530 |
| Budesonide-Formoterol | 16 | $4,478 | $280 |
| Esomeprazole Magnesium | 12 | $2,440 | $203 |
| Proair Hfa | 19 | $2,326 | $122 |
| Ventolin Hfa | 28 | $1,766 | $63 |
| Montelukast | 45 | $1,461 | $32 |
| Dextroamphetamine-Amphetamine | 16 | $1,118 | $70 |
| Proair Respiclick | 13 | $932 | $72 |
| Modafinil | 15 | $508 | $34 |
| Prednisone | 39 | $229 | $6 |
| Pramipexole Dihydrochloride | 18 | $216 | $12 |
| Methylphenidate | 12 | $198 | $17 |
| Fluticasone Propionate | 12 | $178 | $15 |
| Temazepam | 12 | $155 | $13 |
| Azithromycin | 11 | $139 | $13 |
| Trazodone | 18 | $77 | $4 |
| Clonazepam | 13 | $58 | $4 |
| Doxycycline Hyclate | 11 | $50 | $5 |
2021: 40 drugs
| Opsumit | 31 | $353,044 | $11,389 |
| Ofev | 17 | $200,218 | $11,778 |
| Trelegy Ellipta | 143 | $107,164 | $749 |
| Anoro Ellipta | 83 | $38,739 | $467 |
| Tadalafil | 24 | $36,548 | $1,523 |
| Symbicort | 64 | $36,074 | $564 |
| Spiriva | 43 | $34,453 | $801 |
| Breo Ellipta | 70 | $29,038 | $415 |
| Spiriva Respimat | 52 | $27,233 | $524 |
| Stiolto Respimat | 41 | $25,777 | $629 |
| Combivent Respimat | 34 | $16,359 | $481 |
| Daliresp | 31 | $15,625 | $504 |
| Albuterol Sulfate Hfa | 249 | $13,318 | $53 |
| Bevespi Aerosphere | 27 | $12,971 | $480 |
| Advair Diskus | 12 | $12,808 | $1,067 |
| Flovent Hfa | 20 | $11,848 | $592 |
| Breztri Aerosphere | 17 | $11,232 | $661 |
| Wixela Inhub | 30 | $7,813 | $260 |
| Budesonide-Formoterol | 24 | $7,014 | $292 |
| Incruse Ellipta | 14 | $6,821 | $487 |
| Fluticasone-Salmeterol | 11 | $3,302 | $300 |
| Ventolin Hfa | 41 | $2,740 | $67 |
| Striverdi Respimat | 11 | $2,462 | $224 |
| Proair Hfa | 27 | $2,193 | $81 |
| Dextroamphetamine-Amphetamine | 23 | $2,181 | $95 |
| Esomeprazole Magnesium | 12 | $2,111 | $176 |
| Pramipexole Dihydrochloride | 63 | $1,070 | $17 |
| Levalbuterol Tartrate Hfa | 11 | $651 | $59 |
| Fluticasone Propionate | 21 | $541 | $26 |
| Montelukast | 70 | $478 | $7 |
| Methylphenidate | 23 | $461 | $20 |
| Temazepam | 19 | $437 | $23 |
| Modafinil | 14 | $325 | $23 |
| Prednisone | 61 | $321 | $5 |
| Oxycodone | 13 | $144 | $11 |
| Tamsulosin | 12 | $48 | $4 |
| Furosemide | 14 | $46 | $3 |
| Omeprazole | 13 | $45 | $3 |
| Trazodone | 13 | $22 | $2 |
| Amlodipine Besylate | 12 | $18 | $1 |
2020: 44 drugs
| Ofev | 38 | $410,524 | $10,803 |
| Opsumit | 25 | $257,306 | $10,292 |
| Trelegy Ellipta | 147 | $94,135 | $640 |
| Ambrisentan | 12 | $44,349 | $3,696 |
| Symbicort | 78 | $35,421 | $454 |
| Alyq | 15 | $34,050 | $2,270 |
| Spiriva | 53 | $31,770 | $599 |
| Breo Ellipta | 59 | $25,719 | $436 |
| Advair Diskus | 40 | $25,519 | $638 |
| Stiolto Respimat | 42 | $23,696 | $564 |
| Anoro Ellipta | 43 | $21,352 | $497 |
| Spiriva Respimat | 39 | $20,042 | $514 |
| Tadalafil | 27 | $15,210 | $563 |
| Flovent Hfa | 26 | $12,814 | $493 |
| Daliresp | 26 | $12,357 | $475 |
| Combivent Respimat | 24 | $10,772 | $449 |
| Incruse Ellipta | 24 | $8,478 | $353 |
| Wixela Inhub | 34 | $7,833 | $230 |
| Albuterol Sulfate Hfa | 129 | $6,727 | $52 |
| Ventolin Hfa | 65 | $4,538 | $70 |
| Proair Hfa | 48 | $4,361 | $91 |
| Budesonide-Formoterol | 13 | $3,775 | $290 |
| Dulera | 12 | $3,743 | $312 |
| Xopenex Hfa | 23 | $2,404 | $105 |
| Striverdi Respimat | 11 | $2,378 | $216 |
| Arnuity Ellipta | 11 | $2,046 | $186 |
| Dextroamphetamine-Amphetamine | 24 | $1,732 | $72 |
| Proair Respiclick | 19 | $1,231 | $65 |
| Modafinil | 19 | $965 | $51 |
| Temazepam | 22 | $673 | $31 |
| Pramipexole Dihydrochloride | 42 | $525 | $13 |
| Fluticasone Propionate | 30 | $521 | $17 |
| Methylphenidate | 22 | $454 | $21 |
| Montelukast | 63 | $361 | $6 |
| Oxycodone | 20 | $293 | $15 |
| Clonazepam | 19 | $288 | $15 |
| Doxycycline Hyclate | 16 | $255 | $16 |
| Prednisone | 59 | $232 | $4 |
| Azithromycin | 17 | $148 | $9 |
| Tamsulosin | 15 | $133 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $130 | $9 |
| Omeprazole | 12 | $128 | $11 |
| Amlodipine Besylate | 12 | $45 | $4 |
| Furosemide | 14 | $30 | $2 |
2019: 43 drugs
| Ofev | 31 | $319,226 | $10,298 |
| Opsumit | 16 | $161,602 | $10,100 |
| Esbriet | 13 | $92,418 | $7,109 |
| Trelegy Ellipta | 120 | $82,347 | $686 |
| Tadalafil | 43 | $67,641 | $1,573 |
| Symbicort | 80 | $33,298 | $416 |
| Alyq | 12 | $27,246 | $2,271 |
| Breo Ellipta | 50 | $24,506 | $490 |
| Anoro Ellipta | 57 | $24,381 | $428 |
| Spiriva | 38 | $21,775 | $573 |
| Spiriva Respimat | 38 | $17,092 | $450 |
| Stiolto Respimat | 37 | $16,355 | $442 |
| Advair Diskus | 33 | $15,273 | $463 |
| Ventolin Hfa | 158 | $10,386 | $66 |
| Combivent Respimat | 23 | $9,856 | $429 |
| Daliresp | 16 | $8,222 | $514 |
| Bevespi Aerosphere | 19 | $7,138 | $376 |
| Incruse Ellipta | 20 | $6,918 | $346 |
| Flovent Hfa | 20 | $6,822 | $341 |
| Proair Hfa | 63 | $6,774 | $108 |
| Dulera | 17 | $6,460 | $380 |
| Serevent Diskus | 15 | $6,123 | $408 |
| Albuterol Sulfate Hfa | 73 | $3,482 | $48 |
| Dymista | 12 | $2,400 | $200 |
| Striverdi Respimat | 11 | $2,245 | $204 |
| Dextroamphetamine-Amphetamine | 30 | $1,880 | $63 |
| Sildenafil Citrate | 11 | $1,473 | $134 |
| Modafinil | 16 | $1,225 | $77 |
| Xopenex Hfa | 14 | $1,037 | $74 |
| Montelukast | 57 | $542 | $10 |
| Diltiazem 24hr Er (Cd) | 13 | $402 | $31 |
| Temazepam | 19 | $397 | $21 |
| Methylphenidate | 18 | $377 | $21 |
| Pramipexole Dihydrochloride | 33 | $370 | $11 |
| Oxycodone | 21 | $245 | $12 |
| Doxycycline Hyclate | 16 | $230 | $14 |
| Prednisone | 47 | $218 | $5 |
| Fluticasone Propionate | 19 | $176 | $9 |
| Tamsulosin | 17 | $134 | $8 |
| Nortriptyline | 11 | $105 | $10 |
| Omeprazole | 13 | $95 | $7 |
| Furosemide | 17 | $62 | $4 |
| Amlodipine Besylate | 13 | $43 | $3 |
2018: 45 drugs
| Tracleer | 21 | $235,777 | $11,227 |
| Opsumit | 23 | $218,913 | $9,518 |
| Letairis | 18 | $174,580 | $9,699 |
| Ofev | 18 | $172,515 | $9,584 |
| Esbriet | 21 | $163,278 | $7,775 |
| Adcirca | 39 | $122,656 | $3,145 |
| Symbicort | 103 | $37,967 | $369 |
| Tadalafil | 14 | $34,698 | $2,478 |
| Spiriva | 56 | $28,687 | $512 |
| Trelegy Ellipta | 42 | $27,919 | $665 |
| Advair Diskus | 50 | $24,188 | $484 |
| Anoro Ellipta | 54 | $22,750 | $421 |
| Spiriva Respimat | 41 | $20,418 | $498 |
| Breo Ellipta | 38 | $18,583 | $489 |
| Incruse Ellipta | 40 | $14,479 | $362 |
| Stiolto Respimat | 31 | $11,889 | $384 |
| Serevent Diskus | 29 | $11,833 | $408 |
| Sildenafil | 11 | $10,638 | $967 |
| Ventolin Hfa | 139 | $9,741 | $70 |
| Daliresp | 26 | $9,666 | $372 |
| Flovent Hfa | 23 | $8,750 | $380 |
| Proair Hfa | 108 | $8,261 | $76 |
| Combivent Respimat | 13 | $5,798 | $446 |
| Dulera | 15 | $5,106 | $340 |
| Advair Hfa | 11 | $5,074 | $461 |
| Theophylline Anhydrous | 13 | $3,110 | $239 |
| Dymista | 11 | $3,093 | $281 |
| Dextroamphetamine-Amphetamine | 22 | $1,830 | $83 |
| Xopenex Hfa | 12 | $1,454 | $121 |
| Montelukast | 79 | $811 | $10 |
| Azithromycin | 15 | $718 | $48 |
| Fluticasone Propionate | 41 | $469 | $11 |
| Pramipexole Dihydrochloride | 57 | $449 | $8 |
| Temazepam | 34 | $357 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $306 | $25 |
| Doxycycline Hyclate | 22 | $262 | $12 |
| Olopatadine | 11 | $249 | $23 |
| Prednisone | 38 | $242 | $6 |
| Clonazepam | 41 | $231 | $6 |
| Oxycodone | 18 | $144 | $8 |
| Tamsulosin | 15 | $118 | $8 |
| Warfarin | 13 | $105 | $8 |
| Omeprazole | 14 | $92 | $7 |
| Hydralazine | 11 | $65 | $6 |
| Amlodipine Besylate | 12 | $65 | $5 |
2017: 43 drugs
| Opsumit | 30 | $260,724 | $8,691 |
| Tracleer | 22 | $230,304 | $10,468 |
| Letairis | 21 | $194,656 | $9,269 |
| Esbriet | 17 | $140,054 | $8,238 |
| Adcirca | 34 | $96,094 | $2,826 |
| Advair Diskus | 75 | $40,721 | $543 |
| Spiriva | 79 | $39,109 | $495 |
| Symbicort | 110 | $34,910 | $317 |
| Breo Ellipta | 88 | $34,803 | $395 |
| Spiriva Respimat | 55 | $20,334 | $370 |
| Incruse Ellipta | 48 | $19,041 | $397 |
| Sildenafil | 13 | $11,741 | $903 |
| Proair Hfa | 147 | $11,127 | $76 |
| Combivent Respimat | 32 | $11,111 | $347 |
| Ventolin Hfa | 164 | $10,892 | $66 |
| Flovent Hfa | 29 | $9,550 | $329 |
| Daliresp | 23 | $9,172 | $399 |
| Serevent Diskus | 22 | $7,759 | $353 |
| Qvar | 26 | $7,209 | $277 |
| Anoro Ellipta | 11 | $4,750 | $432 |
| Dulera | 16 | $4,669 | $292 |
| Armodafinil | 12 | $2,545 | $212 |
| Striverdi Respimat | 11 | $1,963 | $178 |
| Montelukast | 160 | $1,927 | $12 |
| Xopenex Hfa | 12 | $1,675 | $140 |
| Dextroamphetamine-Amphetamine | 22 | $1,480 | $67 |
| Theophylline Anhydrous | 18 | $1,396 | $78 |
| Fentanyl | 14 | $974 | $70 |
| Pramipexole Dihydrochloride | 65 | $940 | $14 |
| Methylphenidate | 15 | $759 | $51 |
| Proair Respiclick | 14 | $755 | $54 |
| Fluticasone Propionate | 49 | $674 | $14 |
| Azithromycin | 16 | $456 | $29 |
| Prednisone | 55 | $356 | $6 |
| Doxycycline Hyclate | 23 | $332 | $14 |
| Tamsulosin | 19 | $248 | $13 |
| Clonazepam | 28 | $157 | $6 |
| Oxycodone | 11 | $151 | $14 |
| Levocetirizine Dihydrochloride | 11 | $125 | $11 |
| Temazepam | 24 | $125 | $5 |
| Omeprazole | 15 | $94 | $6 |
| Amlodipine Besylate | 12 | $66 | $6 |
| Furosemide | 12 | $30 | $2 |
2016: 54 drugs
| Opsumit | 46 | $358,268 | $7,788 |
| Tracleer | 36 | $332,026 | $9,223 |
| Zemaira | 12 | $246,666 | $20,556 |
| Adcirca | 42 | $109,097 | $2,598 |
| Letairis | 12 | $103,755 | $8,646 |
| Esbriet | 13 | $87,156 | $6,704 |
| Symbicort | 245 | $77,604 | $317 |
| Advair Diskus | 120 | $65,276 | $544 |
| Spiriva | 120 | $51,985 | $433 |
| Spiriva Respimat | 71 | $24,362 | $343 |
| Combivent Respimat | 52 | $16,462 | $317 |
| Proair Hfa | 210 | $14,855 | $71 |
| Daliresp | 33 | $11,392 | $345 |
| Ventolin Hfa | 160 | $10,662 | $67 |
| Sildenafil | 23 | $9,720 | $423 |
| Qvar | 41 | $9,518 | $232 |
| Tudorza Pressair | 21 | $8,793 | $419 |
| Breo Ellipta | 20 | $8,138 | $407 |
| Advair Hfa | 16 | $7,686 | $480 |
| Flovent Hfa | 21 | $7,302 | $348 |
| Anoro Ellipta | 18 | $7,055 | $392 |
| Dulera | 14 | $4,366 | $312 |
| Alvesco | 18 | $4,080 | $227 |
| Incruse Ellipta | 11 | $3,199 | $291 |
| Nasonex | 11 | $3,039 | $276 |
| Mometasone Furoate | 13 | $3,007 | $231 |
| Prograf | 12 | $2,647 | $221 |
| Montelukast | 174 | $2,624 | $15 |
| Xopenex Hfa | 15 | $1,810 | $121 |
| Proair Respiclick | 32 | $1,707 | $53 |
| Azithromycin | 60 | $1,689 | $28 |
| Mycophenolate Mofetil | 12 | $1,561 | $130 |
| Dextroamphetamine-Amphetamine | 17 | $1,495 | $88 |
| Theophylline Anhydrous | 28 | $1,224 | $44 |
| Fentanyl | 11 | $843 | $77 |
| Pramipexole Dihydrochloride | 75 | $769 | $10 |
| Prednisone | 97 | $685 | $7 |
| Fluticasone Propionate | 61 | $642 | $11 |
| Doxycycline Hyclate | 25 | $501 | $20 |
| Methylphenidate | 11 | $477 | $43 |
| Methotrexate | 15 | $446 | $30 |
| Tamsulosin | 20 | $275 | $14 |
| Pravastatin | 14 | $257 | $18 |
| Warfarin | 21 | $236 | $11 |
| Ropinirole | 20 | $204 | $10 |
| Potassium Chloride | 18 | $202 | $11 |
| Omeprazole | 27 | $181 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $139 | $12 |
| Ranitidine | 13 | $130 | $10 |
| Temazepam | 19 | $101 | $5 |
| Amlodipine Besylate | 13 | $76 | $6 |
| Levofloxacin | 14 | $67 | $5 |
| Clonazepam | 19 | $63 | $3 |
| Ramipril | 12 | $53 | $4 |
2015: 55 drugs
| Tracleer | 34 | $293,735 | $8,639 |
| Opsumit | 37 | $279,605 | $7,557 |
| Zemaira | 12 | $252,600 | $21,050 |
| Adcirca | 49 | $113,077 | $2,308 |
| Letairis | 13 | $100,630 | $7,741 |
| Spiriva | 214 | $82,129 | $384 |
| Symbicort | 246 | $71,367 | $290 |
| Advair Diskus | 113 | $47,518 | $421 |
| Proair Hfa | 376 | $24,052 | $64 |
| Combivent Respimat | 61 | $19,473 | $319 |
| Daliresp | 43 | $13,080 | $304 |
| Advair Hfa | 38 | $12,629 | $332 |
| Breo Ellipta | 43 | $12,578 | $293 |
| Dulera | 47 | $12,319 | $262 |
| Spiriva Respimat | 39 | $12,303 | $315 |
| Qvar | 51 | $12,004 | $235 |
| Tudorza Pressair | 35 | $11,172 | $319 |
| Nasonex | 37 | $8,269 | $223 |
| Nuvigil | 13 | $7,230 | $556 |
| Anoro Ellipta | 17 | $5,181 | $305 |
| Ventolin Hfa | 86 | $4,613 | $54 |
| Alvesco | 21 | $4,348 | $207 |
| Atrovent Hfa | 13 | $3,451 | $265 |
| Rozerem | 11 | $3,118 | $283 |
| Montelukast | 156 | $2,739 | $18 |
| Zafirlukast | 16 | $2,348 | $147 |
| Xopenex Hfa | 25 | $2,208 | $88 |
| Proventil Hfa | 24 | $2,003 | $83 |
| Azithromycin | 84 | $1,995 | $24 |
| Mycophenolate Mofetil | 11 | $1,291 | $117 |
| Theophylline Anhydrous | 43 | $1,283 | $30 |
| Doxycycline Hyclate | 21 | $936 | $45 |
| Prednisone | 155 | $930 | $6 |
| Pramipexole Dihydrochloride | 105 | $886 | $8 |
| Dextroamphetamine-Amphetamine | 14 | $860 | $61 |
| Fluticasone Propionate | 56 | $590 | $11 |
| Proair Respiclick | 11 | $569 | $52 |
| Azathioprine | 16 | $525 | $33 |
| Levofloxacin | 30 | $358 | $12 |
| Pravastatin | 11 | $350 | $32 |
| Ropinirole | 31 | $311 | $10 |
| Amoxicillin-Clavulanate Potass | 20 | $308 | $15 |
| Cefdinir | 12 | $282 | $24 |
| Warfarin | 30 | $275 | $9 |
| Tamsulosin | 12 | $216 | $18 |
| Zolpidem | 16 | $179 | $11 |
| Nystatin | 12 | $175 | $15 |
| Omeprazole | 26 | $161 | $6 |
| Amlodipine Besylate | 25 | $128 | $5 |
| Losartan | 12 | $118 | $10 |
| Chlorhexidine Gluconate | 18 | $102 | $6 |
| Furosemide | 29 | $98 | $3 |
| Ranitidine | 14 | $81 | $6 |
| Clonazepam | 24 | $76 | $3 |
| Temazepam | 12 | $55 | $5 |
2014: 47 drugs
| Tracleer | 43 | $332,101 | $7,723 |
| Opsumit | 15 | $107,084 | $7,139 |
| Letairis | 12 | $86,856 | $7,238 |
| Adcirca | 49 | $78,322 | $1,598 |
| Spiriva | 209 | $72,718 | $348 |
| Advair Diskus | 148 | $56,660 | $383 |
| Symbicort | 185 | $50,206 | $271 |
| Proair Hfa | 368 | $22,079 | $60 |
| Combivent Respimat | 68 | $20,509 | $302 |
| Qvar | 65 | $14,457 | $222 |
| Advair Hfa | 38 | $12,607 | $332 |
| Nuvigil | 17 | $8,627 | $507 |
| Nasonex | 43 | $8,197 | $191 |
| Dulera | 28 | $7,767 | $277 |
| Tudorza Pressair | 22 | $7,086 | $322 |
| Daliresp | 31 | $7,052 | $227 |
| Flovent Hfa | 17 | $4,906 | $289 |
| Montelukast | 172 | $4,730 | $28 |
| Ventolin Hfa | 89 | $4,704 | $53 |
| Atrovent Hfa | 16 | $3,936 | $246 |
| Asmanex | 12 | $3,128 | $261 |
| Xarelto | 11 | $3,118 | $283 |
| Dextroamphetamine-Amphet Er | 12 | $3,082 | $257 |
| Foradil | 13 | $2,767 | $213 |
| Niaspan | 11 | $2,391 | $217 |
| Xopenex Hfa | 26 | $2,034 | $78 |
| Doxycycline Hyclate | 37 | $1,969 | $53 |
| Fluticasone Propionate | 63 | $1,229 | $20 |
| Amphetamine Salt Combo | 20 | $1,172 | $59 |
| Azithromycin | 53 | $1,014 | $19 |
| Proventil Hfa | 15 | $1,012 | $67 |
| Pramipexole Dihydrochloride | 71 | $943 | $13 |
| Prednisone | 139 | $942 | $7 |
| Diltiazem Er | 15 | $619 | $41 |
| Warfarin | 45 | $594 | $13 |
| Theophylline Anhydrous | 35 | $560 | $16 |
| Losartan | 27 | $355 | $13 |
| Amox Tr-Potassium Clavulanate | 26 | $313 | $12 |
| Klor-Con M20 | 18 | $308 | $17 |
| Omeprazole | 24 | $287 | $12 |
| Levofloxacin | 24 | $270 | $11 |
| Furosemide | 50 | $184 | $4 |
| Amlodipine Besylate | 31 | $178 | $6 |
| Clonazepam | 44 | $159 | $4 |
| Zolpidem | 14 | $106 | $8 |
| Ranitidine | 12 | $104 | $9 |
| Periogard | 11 | $68 | $6 |
2013: 40 drugs
| Tracleer | 30 | $209,735 | $6,991 |
| Advair Diskus | 165 | $59,840 | $363 |
| Spiriva | 127 | $38,206 | $301 |
| Symbicort | 120 | $28,579 | $238 |
| Adcirca | 22 | $27,988 | $1,272 |
| Cellcept | 11 | $24,426 | $2,221 |
| Proair Hfa | 251 | $13,846 | $55 |
| Advair Hfa | 39 | $13,345 | $342 |
| Qvar | 53 | $11,540 | $218 |
| Combivent Respimat | 35 | $9,227 | $264 |
| Daliresp | 37 | $7,581 | $205 |
| Ventolin Hfa | 105 | $5,679 | $54 |
| Montelukast | 110 | $4,520 | $41 |
| Nasonex | 25 | $3,930 | $157 |
| Atrovent Hfa | 15 | $3,715 | $248 |
| Combivent | 12 | $2,736 | $228 |
| Amphetamine Salt Combo | 21 | $2,647 | $126 |
| Alvesco | 14 | $2,421 | $173 |
| Avelox | 16 | $1,962 | $123 |
| Pramipexole Dihydrochloride | 47 | $1,420 | $30 |
| Fluticasone Propionate | 47 | $1,401 | $30 |
| Azithromycin | 53 | $1,030 | $19 |
| Doxycycline Hyclate | 19 | $900 | $47 |
| Metoprolol | 16 | $666 | $42 |
| Methylphenidate | 12 | $517 | $43 |
| Prednisone | 135 | $495 | $4 |
| Amox Tr-Potassium Clavulanate | 19 | $481 | $25 |
| Theophylline Anhydrous | 25 | $467 | $19 |
| Ipratropium | 15 | $374 | $25 |
| Levofloxacin | 32 | $341 | $11 |
| Klor-Con M20 | 12 | $337 | $28 |
| Nystatin | 11 | $301 | $27 |
| Warfarin | 25 | $232 | $9 |
| Levothyroxine | 19 | $228 | $12 |
| Omeprazole | 12 | $182 | $15 |
| Alendronate | 21 | $146 | $7 |
| Furosemide | 25 | $113 | $5 |
| Zolpidem | 22 | $95 | $4 |
| Lisinopril-Hydrochlorothiazide | 13 | $83 | $6 |
| Allopurinol | 12 | $48 | $4 |
Money from drug and device companies
$2,920 in 2025
| 2025 | 28 | 70 | None | $2,920 |
| 2024 | 16 | 64 | None | $1,200 |
| 2023 | 20 | 53 | None | $1,004 |
| 2022 | 13 | 26 | None | $491 |
| 2021 | 14 | 30 | None | $483 |
| 2020 | 17 | 45 | None | $714 |
| 2019 | 19 | 111 | None | $1,514 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $1,371 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $242 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Hyqvia | $109 | 4 payments
|
| Noctrix Health | Nidra | $105 | 1 payment
|
| Grifols USA | Xembify | $100 | 4 payments
|
| Genzyme | Dupixent | $96 | 3 payments
|
See all 69 published payments
| Grifols USA | Meals · 2025-12-18 | Xembify | $25 |
| Avadel CNS Pharmaceuticals | Meals · 2025-12-03 | Lumryz | $20 |
| Axsome Therapeutics | Meals · 2025-11-24 | Sunosi | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-17 | Hyqvia | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-12 | Fasenra | $29 |
| Genzyme | Meals · 2025-11-11 | Dupixent | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-11-05 | Dupixent | $37 |
| Insmed | Meals · 2025-11-04 | Arikayce | $14 |
| Electromed | Meals · 2025-10-29 | Smartvest | $8 |
| Axsome Therapeutics | Meals · 2025-10-27 | Sunosi | $21 |
| Electromed | Meals · 2025-10-23 | Smartvest | $2 |
| Sanofi-Aventis U.S. | Education · 2025-10-23 | Dupixent | $79 |
| Harmony Biosciences | Meals · 2025-10-22 | Wakix | $28 |
| Inspire Medical Systems | Meals · 2025-10-22 | Inspire | $102 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Fasenra | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-24 | Fasenra | $25 |
| GlaxoSmithKline | Meals · 2025-09-17 | Nucala | $16 |
| Inspire Medical Systems | Travel · 2025-09-15 | Inspire | $228 |
| Inspire Medical Systems | Travel · 2025-09-13 | Inspire | $32 |
| Inspire Medical Systems | Meals · 2025-09-12 | Inspire | $96 |
| Inspire Medical Systems | Meals · 2025-09-11 | Inspire | $34 |
| Viatris Specialty | Meals · 2025-09-10 | Yupelri | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-21 | Hyqvia | $27 |
| United Therapeutics | Meals · 2025-08-07 | Remodulin | $28 |
| Lilly USA | Meals · 2025-08-06 | Zepbound | $31 |
| ANI Pharmaceuticals | Meals · 2025-08-06 | Purified Cortrophin Gel | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-04 | Tezspire | $7 |
| Grifols USA | Meals · 2025-07-30 | Prolastin-C Liquid | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-14 | Glassia | $32 |
| Viatris Specialty | Meals · 2025-07-14 | Yupelri | $15 |
| Inspire Medical Systems | Travel · 2025-07-07 | Inspire | $821 |
| Axsome Therapeutics | Meals · 2025-07-02 | Sunosi | $22 |
| Inspire Medical Systems | Meals · 2025-06-30 | Inspire | $37 |
| Electromed | Meals · 2025-06-26 | Smartvest | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-24 | Fasenra | $122 |
| Jazz Pharmaceuticals | Meals · 2025-06-23 | Xywav | $25 |
| Genzyme | Meals · 2025-06-18 | Dupixent | $26 |
| Harmony Biosciences | Meals · 2025-06-17 | Wakix | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-10 | Tezspire | $20 |
| Grifols USA | Meals · 2025-06-09 | Xembify | $29 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-29 | Ofev | $29 |
| Electromed | Meals · 2025-05-28 | Smartvest | $12 |
| Merck Sharp & Dohme | Meals · 2025-05-27 | Zerbaxa | $21 |
| United Therapeutics | Meals · 2025-05-21 | Tyvaso | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-15 | Breztri | $14 |
| Noctrix Health | Meals · 2025-05-09 | Nidra | $105 |
| Amgen | Meals · 2025-05-06 | Tezspire | $22 |
| CSL Behring | Meals · 2025-05-01 | Hizentra | $23 |
| Electromed | Meals · 2025-04-22 | Smartvest | $17 |
| Actelion Pharmaceuticals US | Meals · 2025-04-17 | Opsumit | $34 |
| Verona Pharma | Meals · 2025-04-16 | Ohtuvayre | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-04-09 | Dupixent | $25 |
| Electromed | Meals · 2025-04-01 | Smartvest | $1 |
| Grifols USA | Meals · 2025-03-18 | Xembify | $30 |
| Harmony Biosciences | Meals · 2025-03-11 | Wakix | $26 |
| Lilly USA | Meals · 2025-03-10 | Zepbound | $16 |
| Electromed | Meals · 2025-02-27 | Smartvest | $11 |
| Inspire Medical Systems | Meals · 2025-02-24 | Inspire | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-02-12 | Dupixent | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-02-11 | Acthar | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-06 | Glassia | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-05 | Ofev | $34 |
| GlaxoSmithKline | Meals · 2025-02-04 | Nucala | $16 |
| Bard Peripheral Vascular | Meals · 2025-01-27 | None | $18 |
| Merck Sharp & Dohme | Meals · 2025-01-23 | Zerbaxa | $16 |
| GlaxoSmithKline | Meals · 2025-01-22 | Trelegy Ellipta | $14 |
| Genzyme | Meals · 2025-01-15 | Dupixent | $36 |
| Tactile Systems Technology | Meals · 2025-01-14 | Flexitouch Plus | $16 |
| Harmony Biosciences | Meals · 2025-01-06 | Wakix | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,200
| AstraZeneca Pharmaceuticals LP | Fasenra | $178 | 9 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $159 | 13 payments
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $129 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $103 | 3 payments
|
| Grifols USA | Xembify | $86 | 4 payments
|
| Electromed | Smartvest | $76 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $72 | 3 payments
|
| Merck Sharp & Dohme | Zerbaxa | $64 | 3 payments
|
| Axsome Therapeutics | Sunosi | $62 | 3 payments
|
| Inspire Medical Systems | Inspire | $55 | 2 payments
|
| Genzyme | Dupixent | $52 | 2 payments
|
| United Therapeutics | Tyvaso | $50 | 2 payments
|
| Insmed | Arikayce | $40 | 2 payments
|
| CSL Behring | Hizentra | $37 | 2 payments
|
| Philips North America | (Eg2) Sleep Other | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $14 | 1 payment
|
2023: $1,004
| GlaxoSmithKline | Trelegy Ellipta | $131 | 10 payments
|
| Axsome Therapeutics | Sunosi | $93 | 4 payments
|
| Pharming Healthcare | Ruconest | $92 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $86 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $82 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $80 | 3 payments
|
| Electromed | Smartvest | $62 | 4 payments
|
| Harmony Biosciences | Wakix | $49 | 2 payments
|
| United Therapeutics | Tyvaso | $43 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $42 | 3 payments
|
| Merck Sharp & Dohme | None | $39 | 2 payments
|
| Insmed | Arikayce | $38 | 2 payments
|
| Amgen | Tezspire | $38 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $29 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $23 | 1 payment
|
| Pfizer | Prevnar 20 | $19 | 1 payment
|
| Genentech USA | Xolair | $17 | 1 payment
|
| Abbvie | Avycaz | $15 | 1 payment
|
| Resmed | Airsense | $14 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $13 | 1 payment
|
2022: $491
| Boehringer Ingelheim Pharmaceuticals | Ofev | $65 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $61 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $56 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $50 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $46 | 2 payments
|
| Genzyme | Dupixent | $36 | 2 payments
|
| Electromed | Smartvest | $32 | 3 payments
|
| Genentech USA | Xolair | $30 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $27 | 2 payments
|
| Philips Electronics North America | (8874) Incourage | $25 | 1 payment
|
| Grifols USA | Xembify | $23 | 1 payment
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $22 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $17 | 1 payment
|
2021: $483
| Actelion Pharmaceuticals US | Uptravi | $74 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $70 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $58 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $52 | 3 payments
|
| United Therapeutics | Tyvaso | $45 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $41 | 3 payments
|
| Advanced Respiratory | Volara System | $28 | 2 payments
|
| Merck Sharp & Dohme | Recarbrio | $18 | 1 payment
|
| Genzyme | Dupixent | $18 | 1 payment
|
| Electromed | Smartvest | $17 | 2 payments
|
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $17 | 1 payment
|
| Insmed | Arikayce | $17 | 1 payment
|
| Resmed | Airsense | $16 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $11 | 1 payment
|
2020: $714
| GlaxoSmithKline | Trelegy Ellipta | $128 | 11 payments
|
| Actelion Pharmaceuticals US | Uptravi | $97 | 4 payments
|
| United Therapeutics | Orenitram | $74 | 3 payments
|
| Philips Electronics North America | (6299) Dreamwear | $70 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $68 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $53 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $29 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $29 | 2 payments
|
| Grifols USA | Prolastin-C Liquid | $29 | 2 payments
|
| Insmed | Arikayce | $27 | 2 payments
|
| Circassia Pharmaceuticals | Duaklir Pressair | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $18 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $17 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $17 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $14 | 1 payment
|
| Harmony Biosciences | Wakix | $13 | 1 payment
|
| Genentech USA | Esbriet | $13 | 1 payment
|
2019: $1,514
| GlaxoSmithKline | Trelegy Ellipta | $241 | 21 payments
|
| Actelion Pharmaceuticals US | Uptravi | $209 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $188 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $142 | 6 payments
|
| Insmed | Arikayce | $121 | 11 payments
|
| Grifols USA | Prolastin-C Liquid | $87 | 6 payments
|
| United Therapeutics | Orenitram | $85 | 4 payments
|
| Merck Sharp & Dohme | Zerbaxa | $68 | 5 payments
|
| Electromed | Smartvest | $63 | 4 payments
|
| Circassia Pharmaceuticals | Tudorza Pressair | $49 | 3 payments
|
| Genentech USA | Xolair | $40 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $40 | 2 payments
|
| Shire North American Group | Glassia | $38 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $34 | 2 payments
|
| Philips Electronics North America | Trilogy 100 | $29 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $26 | 2 payments
|
| BioFire Diagnostics | Biofire Filmarray | $24 | 1 payment
|
| Astellas Pharma US | Cresemba | $16 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144225566
- Licence
- SC 12417
- Trained
- Medical University of South Carolina College of Medicine, 1983 · 43 years ago
- Group
- Anmed Health
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- GA 000477265C, SC 124172
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 2000 East Greenville St, Suite 1100, Anderson, SC, 29621
- NPI first listed
- 2005-06-14
- NPI last updated
- 2012-04-09
This is when the NPI record was last certified, not a medical board exam.